Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: billkirn who wrote (5664)	11/10/1998 2:41:00 PM
From: Steve Fancy	Read Replies (1) \| Respond to of 6136

Hey Bill, with the stock at 40, I have to wonder why some of these big guns continue to maintain a deal is in the works. I think BS had valued the company at around $45 on a buyout basis. I wonder if pipeline news has been changing this valuation. How 'bout $60 (I like to dream). Although I question if they'd sell at these levels also, what happens if and when all these rumors die with not action? Back to $30-$35? In any case the power behind the stock seems to continue on what I consider to be low to moderate volume...suggesting to me that we're not looking at many sellers, and selected buyers. sf